MX2013010687A - Soluciones de dialisis peritoneal que comprenden polimeros de glucosa. - Google Patents

Soluciones de dialisis peritoneal que comprenden polimeros de glucosa.

Info

Publication number
MX2013010687A
MX2013010687A MX2013010687A MX2013010687A MX2013010687A MX 2013010687 A MX2013010687 A MX 2013010687A MX 2013010687 A MX2013010687 A MX 2013010687A MX 2013010687 A MX2013010687 A MX 2013010687A MX 2013010687 A MX2013010687 A MX 2013010687A
Authority
MX
Mexico
Prior art keywords
dialysis solutions
peritoneal dialysis
glucose polymer
glucose polymers
fluid volume
Prior art date
Application number
MX2013010687A
Other languages
English (en)
Other versions
MX362554B (es
Inventor
John Kenneth Leypoldt
Clifford J Holmes
Sujatha Karoor
Catherine M Hoff
Leo Martis
Rahul Tandon
Original Assignee
Baxter Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45888495&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2013010687(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Healthcare Sa filed Critical Baxter Healthcare Sa
Publication of MX2013010687A publication Critical patent/MX2013010687A/es
Publication of MX362554B publication Critical patent/MX362554B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
    • C08L3/02—Starch; Degradation products thereof, e.g. dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Se describen soluciones de diálisis peritoneal que incluyen un polímero de glucosa y métodos para utilizar las soluciones de diálisis. En una modalidad general, la solución de diálisis peritoneal incluye un polímero de glucosa en una cantidad para proporcionar un volumen de fluido de ultrafiltración para una cantidad dada de carbohidrato adsorbido comparado con soluciones de diálisis convencionales que contienen icodextrina como el ingrediente farmacéutico activo. El volumen de fluido de ultrafiltración incrementado para una cantidad dada de carbohidrato adsorbido se obtiene al proporcionar combinaciones específicas de peso molecular promedio en peso, índice de polidispersidad, y concentración del polímero de glucosa en la solución de diálisis.
MX2013010687A 2011-03-18 2012-03-14 Soluciones de dialisis peritoneal que comprenden polimeros de glucosa. MX362554B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161454251P 2011-03-18 2011-03-18
PCT/US2012/028999 WO2012129017A1 (en) 2011-03-18 2012-03-14 Peritoneal dialysis solutions comprising glucose polymers

Publications (2)

Publication Number Publication Date
MX2013010687A true MX2013010687A (es) 2014-03-27
MX362554B MX362554B (es) 2019-01-24

Family

ID=45888495

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010687A MX362554B (es) 2011-03-18 2012-03-14 Soluciones de dialisis peritoneal que comprenden polimeros de glucosa.

Country Status (6)

Country Link
US (1) US8975240B2 (es)
EP (1) EP2685991A1 (es)
JP (2) JP6388475B2 (es)
CN (1) CN103732233B (es)
MX (1) MX362554B (es)
WO (1) WO2012129017A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012230767A1 (en) 2011-03-23 2013-10-31 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
CN106632721B (zh) * 2015-11-03 2020-08-21 华仁药业股份有限公司 葡萄糖聚合物、其制备方法及用途
CN107550928A (zh) * 2016-06-30 2018-01-09 华仁药业股份有限公司 一种葡萄糖聚合物腹膜透析液及其制备工艺
EP3381484A1 (en) 2017-03-31 2018-10-03 Opterion Health AG Carbohydrate composition for dialysis
WO2018237375A1 (en) 2017-06-24 2018-12-27 Nxstage Medical, Inc. METHODS AND SYSTEMS FOR PREPARING AND / OR PROCESSING PERITONEAL DIALYSIS FLUID
US11872337B2 (en) 2018-02-28 2024-01-16 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
CN109394781A (zh) * 2018-11-13 2019-03-01 华仁药业股份有限公司 一种葡萄糖聚合物腹膜透析液的制备方法及其腹膜透析液

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2445839A1 (fr) 1979-01-08 1980-08-01 Roquette Freres Hydrolysat d'amidon eventuellement hydrogene, son procede de preparation et ses applications
WO1982003329A1 (en) 1981-03-31 1982-10-14 David B A Silk Glucose polymers and method of producing same
US4761237A (en) 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
EP0076355A3 (en) 1981-10-01 1983-05-25 Abbott Laboratories Improved peritoneal dialysis solution
GB8404299D0 (en) * 1984-02-18 1984-03-21 Milner Research Ireland Ltd Peritoneal dialysis
US6077836A (en) 1983-01-12 2000-06-20 Ml Laboratotries, Plc Peritoneal dialysis and compositions for use therein
US4886789A (en) 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
GB8300718D0 (en) 1983-01-12 1983-02-16 Milner Research Ireland Ltd Glucose polymer solutions
US6248726B1 (en) 1985-06-22 2001-06-19 M L Laboratories Plc Method of peritoneal dialysis using glucose polymer solutions
ATE106410T1 (de) 1985-06-22 1994-06-15 Ml Lab Plc In kontinuierlicher peritonealdialyse verwendete polymere.
JP2926434B2 (ja) * 1990-07-26 1999-07-28 株式会社林原生物化学研究所 アミロース粒子とその製造方法
AU662146B2 (en) 1991-03-19 1995-08-24 Cytrx Corporation Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
DE4132701A1 (de) 1991-10-01 1993-04-08 Laevosan Gmbh & Co Kg Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung
DE4242926C2 (de) 1992-12-18 1994-12-15 Fresenius Ag Dialyselösung für die Peritonealdialyse
US6306836B1 (en) 1994-01-21 2001-10-23 Baxter International Inc. Peritoneal dialysis solutions containing maltodextrins and amino acids
FR2716199B1 (fr) * 1994-02-15 1996-04-26 Roquette Freres Procédé de fabrication d'un hydrolysat d'amidon à faible indice de polymolécularité, nouvel hydrolysat d'amidon ainsi obtenu et son utilisation en dialyse péritonéale.
US6068705A (en) 1998-04-27 2000-05-30 Roquette Freres Process for producing low De starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products
US6348264B1 (en) 1998-04-27 2002-02-19 Roquette Freres Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products
FR2786775B1 (fr) 1998-12-04 2001-02-16 Roquette Freres Maltodextrines branchees et leur procede de preparation
US20040121982A1 (en) 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
FR2897869B1 (fr) * 2006-02-28 2011-05-06 Roquette Freres Polymeres solubles de glucose hautement branches pour la nutrition enterale, parenterale et pour la dialyse peritoneale
EP2273995B2 (en) * 2008-03-20 2023-11-15 Baxter International Inc. Destruction of microbial products by enzymatic digestion

Also Published As

Publication number Publication date
US20120238525A1 (en) 2012-09-20
CN103732233A (zh) 2014-04-16
MX362554B (es) 2019-01-24
US8975240B2 (en) 2015-03-10
JP2017114886A (ja) 2017-06-29
JP6388475B2 (ja) 2018-09-12
WO2012129017A1 (en) 2012-09-27
EP2685991A1 (en) 2014-01-22
JP2014508171A (ja) 2014-04-03
CN103732233B (zh) 2016-08-10

Similar Documents

Publication Publication Date Title
MX362554B (es) Soluciones de dialisis peritoneal que comprenden polimeros de glucosa.
MX2021002835A (es) Sistema y metodo de deteccion de cloro total en agua para tratamientos con fluidos medicos.
FR2995899B1 (fr) Procede de polymerisation de l'acide (meth)acrylique en solution, solutions de polymeres obtenues et leurs utilisations.
PH12015500781B1 (en) Methods for treatment of alport syndrome
EP2626427A3 (en) Sirna conjugate and preparation method thereof
CO6660473A2 (es) Succinato acetato de hidroxipropil metil celulosa con acetato aumentado y sustitucion de succinato
WO2014025796A3 (en) Piston pump devices
MX352252B (es) Conjugados polimero-carbohidrato-lipidos.
PH12015500702B1 (en) Dialysis a agent comprising acetic acid and acetate, and two-part dialysis agent using same
CL2015003580A1 (es) Conjugados de suministro de polinucleotidos in vivo que tienen acoplamientos sensibles a enzima.
TR201820019T4 (tr) Metilglioksal hidroimidazolonun (MGH1) belirlenmesi aracılığıyla diyabet yönetiminin geliştirilmesine yönelik yöntem ve kit.
ES2571584T3 (es) Preparación de hialuronato de sodio usando un mutante de Streptococcus zooepidemicus
WO2011129588A3 (ko) 경피흡수용 고분자-리포좀 나노복합체 조성물 및 그 제조방법
BR112012027545A2 (pt) composto de fórmula i, composição farmacêutica, uso da composição farmacêutica, uso de um composto e método de modulação do nível de glicose no sangue em um indivíduo
JP2010209349A5 (es)
MX360025B (es) Polvo biocompuesto natural preparado a partir de biomasa de pichia pastoris, metodo de preparacion y su uso como excipiente.
EP2714129A4 (en) APPARATUS RELATING TO PERIODONAL HEMODIALYSIS, HEMODIAFILTRATION, HEMOFILTRATION OR DIALYSIS HAVING FUNCTION TO RAISE TEMPERATURE
WO2016133912A3 (en) Pump with external controlled compression and methods of pumping with external controlled compression
NZ602996A (en) Therapy prediction and optimization for renal failure blood therapy, especially home hemodialysis
GB201306347D0 (en) Fluid conveyance safety devices, methods and systems
MX2015001508A (es) El uso de antitrombina en la oxigenacion por membrana extracorporea.
MX2014013101A (es) Solucion de gemcitabina lista para infundir.
MY175499A (en) Method for polymerizing meth(acrylic) acid in a solution, polymer solutions obtained and uses thereof
WO2014059420A3 (en) Irrigating cannula system and methods
JP2013544265A5 (es)

Legal Events

Date Code Title Description
FG Grant or registration